In these studies, the use of selective COX-2 inhibitor was associated to a 45% increase in the incidence of vascular events rate ratio 1.45; p = 0.005, without significant heterogeneity between the rate ratio of events.
En estos estudios, el uso de inhibidor selectivo de la COX-2 se asoció al aumento del 45% en la incidencia de eventos vasculares rate ratio 1,45; p = 0,005, sin heterogeneidad significante entre el rate ratio de eventos.
Nesses estudos, o uso de inibidor seletivo da COX-2 associou-se ao aumento de 45% na incidência de eventos vasculares rate ratio 1,45; p = 0,005, sem heterogeneidade significante entre o rate ratio de eventos.